Study Chair
Bruce McCarthy, MD
Embera NeuroTherapeutics, Inc.
- 2 trials
- 1 compound
Therapeutic focus
- Tobacco Use Disorder
- Cocaine Use Disorder
All trials (2)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT04933916 | Phase 1/2 | Discontinued | EMB-001 (metyrapone/oxazepam) | Embera NeuroTherapeutics, Inc. |
| NCT04501874 | Phase 2 | Completed | EMB-001 (metyrapone/oxazepam) | Embera NeuroTherapeutics, Inc. |
Compounds studied
Trial sites (6)
- Philadelphia, Pennsylvania, United States
- San Diego, California, United States
- Miami Lakes, Florida, United States
- Raleigh, North Carolina, United States
- Miami, Florida, United States
- Charleston, South Carolina, United States
Investigator and site data mirrored fromClinicalTrials.gov (public domain).